Author:
Wei Huanhuan,Shao Zehua,Tai Jianqing,Fu Fangfang,Lv Chuanjian,Guo Zhiping,Wu Yaping,Chen Lijuan,Bai Yan,Wu Qingxia,Yu Xuan,Mu Xinling,Shao Fengmin,Wang Meiyun
Abstract
Abstract
Objective
To explore the characteristics of peripheral blood, high resolution computed tomography (HRCT) imaging and the radiomics signature (RadScore) in patients infected with delta variant virus under different coronavirus disease (COVID-19) vaccination status.
Methods
123 patients with delta variant virus infection collected from November 1, 2021 to March 1, 2022 were analyzed retrospectively. According to COVID-19 vaccination Status, they were divided into three groups: Unvaccinated group, partially vaccinated group and full vaccination group. The peripheral blood, chest HRCT manifestations and RadScore of each group were analyzed and compared.
Results
The mean lymphocyte count 1.22 ± 0.49 × 10^9/L, CT score 7.29 ± 3.48, RadScore 0.75 ± 0.63 in the unvaccinated group; The mean lymphocyte count 1.55 ± 0.70 × 10^9/L, CT score 5.27 ± 2.72, RadScore 1.03 ± 0.46 in the partially vaccinated group; The mean lymphocyte count 1.87 ± 0.70 × 10^9/L, CT score 3.59 ± 3.14, RadScore 1.23 ± 0.29 in the fully vaccinated group. There were significant differences in lymphocyte count, CT score and RadScore among the three groups (all p < 0.05); Compared with the other two groups, the lung lesions in the unvaccinated group were more involved in multiple lobes, of which 26 cases involved the whole lung.
Conclusions
Through the analysis of clinical features, pulmonary imaging features and radiomics, we confirmed the positive effect of COVID-19 vaccine on pulmonary inflammatory symptoms and lymphocyte count (immune system) during delta mutant infection.
Funder
Henan provincial science and technology research projects
Medical Science and Technology Research Project of Henan Province
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference33 articles.
1. Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–3. https://doi.org/10.1016/S0140-6736(20)30185-9.
2. Gulati A, Pomeranz C, Qamar ZPJ, et al. A comprehensive review of manifestations of novel coronaviruses in the context of deadly COVID-19 global pandemic. Am J Med Sci. 2020;360(1):5–34. https://doi.org/10.1016/j.amjms.2020.05.006.
3. Choudhary J, Dheeman S, Sharma V, et al. Insights of severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic: a current review. Biol Proced Online. 2021;23(1):5. https://doi.org/10.1186/s12575-020-00141-5.
4. Torjesen I. Covid-19: Delta variant is now UK’s most dominant strain and spreading through schools. BMJ Clin Res. 2021;373:n1445. https://doi.org/10.1136/bmj.n1445.
5. EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL. Assessing SARS-CoV-2 circulation, variants of concern, non-pharmaceutical interventions and vaccine rollout in the EU/EEA, 15th update-10 June 2021.ECDC: Stockholm; 2021. https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-sars-cov-2-circulation-variants-concern.